$55MVenture, 17 June 2025
Funds completion of the RESPONDER-HF pivotal trial toward FDA approval.
- Amount
- $55M
- Stage
- Venture
- Announced
- 17 June 2025
- Lead
- Third Rock Ventures
- Other investors
- General Catalyst, AccelMed, Lumira Ventures
- Use of funds
- Funds completion of the RESPONDER-HF pivotal trial toward FDA approval.
- Checked
- Announced by the company
- Sources
- Corvia Medical raises $55M for heart failure treatment (date approx) corviamedical.com
Corvia Medical raises $55M for heart failure treatment (date approx) pulse2.com